Entries by aaron

Delhi Vigilance Dept calls for CBI probe into suspected spurious drugs

The Delhi government’s Directorate of Vigilance has sent the matter of suspected spurious drugs to the Union Home Ministry, urging a thorough investigation by the Central Bureau of Investigation (CBI). The Directorate of Vigilance, in a formal letter to the Union Home Ministry on Thursday, said, “Assigning the matter if reported supply of not of […]

WBCERC has no authority to adjudicate Medical Negligence Cases: Calcutta High Court

Kolkata: In a major decision, the Calcutta High Court bench has clearly iterated that matters concerning the issues of medical negligence cannot be adjudicated by the West Bengal Clinical Establishment Regulatory Commission (WBCERC). Clarifying its stand in this regard, the HC bench comprising Justice Arijit Banerjee and Justice Apurba Sinha Ray noted, “The negligence in […]

Bayer Pharma gets CDSCO Panel nod to study Asundexian 50mg tablets

New Delhi: Bayer Pharmaceutical has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to conduct the phase III clinical trial of Asundexian (BAY 2433334) tablets. However, this approval is subject to the condition that clarity on PFO (patent foramen ovale) and arterial episode findings in Echo […]

Delhi reports first Covid JN.1 case

Following the identification of the first case of the Covid-19 sub-variant JN.1 in the national capital, the All India Institute of Medical Sciences (AIIMS) in Delhi has released guidelines for managing suspected or positive Covid patients in hospitals. In response to a meeting with department heads, the AIIMS Delhi Director has directed the establishment of […]

Revise BE study protocol: CDSCO Panel tells Akum Pharma on FDC of Chlorthalidone, Cilnidipine, Bisoprolol film-coated tablet

New Delhi: Citing that individual and innovators’ products should be taken as a reference product in the proposed bioequivalence study protocol, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has opined the drug major Akum Pharmaceutical to revise the bioequivalence (BE) study protocol for Chlorthalidone IP 6.25mg plus Cilnidipine […]

Cell, gene therapy to rule pharma sector in 2024: Report

New Delhi: Cell and gene therapy (CGT) will have the greatest impact on the pharmaceutical industry in 2024, according to a report on Thursday. The report by GlobalData, a data and analytics company, is based on a survey of 115 healthcare industry professionals. It revealed that 18 per cent of industry professionals were convinced that CGT […]

Critical Care Review In 2023: Notable Achievements And Advancements – Dr Deepak V

Critical care, once a nascent speciality, gained prominence when ICUs were inundated with COVID-19 patients in 2020. The demand for critical care has since escalated across healthcare institutions due to an ageing population. As a result, the speciality is now branching into various subspecialties such as neurocritical care, transplant critical care, oncological critical care, and […]

Top Ten Landmark Trials Across Neuroscience – Dr Tharun Krishna

Practice parameters in clinical neuroscience have been fine-tuned in line with hard evidence to a large measure by many randomised control trials (RCT) over the years. Many RCTs have been well conceived and executed, but some have been dodged by controversies on sample size, design, and biases. Those that have stood the test of time […]